With $36.7B In Cash, Bank of America Expects Gilead To Shop For Complements To Drug Pipeline
February 07, 2018 at 14:37 PM EST
Gilead Sciences, Inc. (NASDAQ: GILD) announced fourth-quarter results Tuesday that revealed better-than-expected top- and bottom-line ...